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Synthesis of 2-aminoBODIPYs by palladium catalysed amination 
Rua B. Alnoman,a,b Patrycja Stachelek,a Julian G. Knight,*a  Anthony Harriman,a and Paul G. 
Waddella 
Palladium catalysed coupling of the 2-iodoBODIPY 3 with a range of anilines and a primary alkylamine succeeds in generating 
the corresponding 2-aminoBODIPYs. These 2-aminoBODIPY derivatives are non-emissive and quantum chemical calculations 
and electrochemistry are consistent with charge transfer from the amine substituent. Attenuation of this charge transfer 
pathway by conversion of the 1,2-phenylenediamine derivative 9 into the corresponding benzimidazolone 10 restores the 
fluorescence and has been used as the basis for a fluorescence sensor for phosgene.
Introduction 
The 4,4-difluoro-4-bora-3a,4a-diaza-s-indacenes (BODIPYs, Fig. 
1) are a class of organic dyes typically characterised by sharp 
absorption and emission spectra, excitation and emission 
wavelengths in the visible/near infra red region, high molar 
absorption coefficients, high quantum yields of fluorescence, 
high photostability and resistance to chemical degradation. The 
synthetic accessibility of BODIPYs enables elaboration of the 
core structure in order to tune the photophysical properties.1 
BODIPYs have consequently found widespread application 
including use as fluorescence sensors,2 as biomolecular imaging 
agents,3 in photodynamic therapy,4 as laser dyes,5 in 
electroluminescence,6 and in electron-transfer applications 
such as dye-sensitized solar cells.7 
 
 
 
 
 
Figure 1 Numbering scheme for 4,4-difluoro-4-bora-3a,4a-diaza-s-
indacenes (BODIPY) 
 
There is a growing number of amine-functionalised BODIPYs in 
which the strongly electron donating amino group results in 
fluorescence quenching by intramolecular charge transfer (ICT) 
or photoelectron transfer (PET) to the excited state. This 
electron donation can be attenuated by coordination of the 
nitrogen lone pair to a Lewis or Brønsted acid, leading to 
restoration of the BODIPY fluorescence, and this property has 
been frequently employed in the design of ‘switch-on’ 
fluorescence sensors.2,3,8 
In these systems the amino group is typically appended to a 
substituent. The direct attachment of amine nitrogen to the 
BODIPY core is less common and such systems have been the 
focus of detailed structural and photophysical investigations 
motivated by the high level of current interest in elucidating the 
effects of substituents on the properties of these fluorophores.9 
Synthesis of directly-aminated BODIPYs relies almost exclusively 
on nucleophilic substitution (SNAr) of BODIPY electrophiles 
carrying a suitable nucleofuge (halogen, ether, thioether, or 
hydrogen under oxidative conditions).9,10 Nucleophilic 
amination (SNAr) is electronically restricted to the 1, 3, 5, 7 and 
8 positions of the BODIPY (Fig. 1) because attack at these 
positions allows the resulting intermediate anion to be 
delocalised onto one of the nitrogen atoms. 
The effect of amino substituents on the energy of absorption is 
known to be dependent on the position of substitution: 8-amino 
substitution is reported to lead to a significant blue-shift due to 
LUMO destabilisation by an antibonding interaction between 
nitrogen and C89d and the size of the blue-shift is reduced in 
systems in which coplanarity between the amine and BODIPY 
core is sterically disfavoured;9k 3-amino substitution of an 8-
methyl BODIPY leads to red-shifted absorption which has been 
ascribed simply to an increase in the length of the conjugated 
system.9g The effect of direct 2-amino substitution on the 
photophysical properties of BODIPY is therefore of some 
interest. We were therefore interested in accessing 2-
aminoBODIPY derivatives, which have been relatively neglected 
presumably because of the lack of convenient synthetic routes. 
Amino substitution has been introduced by electrophilic 
nitration followed by reduction but this approach is limited to 
the parent 2-NH2 substituent.9g,j The resulting α-unsubstituted 
2-NH2 derivative was also reported to be very unstable and so 
no photophysical data was reported.9g The 2-NH2 group has also 
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been introduced by palladium-catalysed substitution of a 2-
bromoBODIPY with benzophenone imine followed by hydrolysis 
of the resulting 2-iminoBODIPY.9e,f This approach is also 
structurally limited and uses a rather high palladium loading (5 
– 40 mol%). The presence of phenyl substituents in the 3,5-
positions or a 4-nitrophenyl group in the BODIPY 6-position was 
reported to stabilise the resulting 2-NH2-substituted BODIPYs 
but no photophysical data was reported for these compounds. 
Attempted palladium catalysed amination of a 2-bromoBODIPY 
has been reported to fail, instead giving a complex mixture from 
which a 2-aminoBODIPY was not isolated.11 
We report herein the synthesis of 2-alkyl- and 2-aryl-amino 
BODIPYs by palladium catalysed Buchwald-Hartwig amination 
of the corresponding 2-iodoBODIPY derivatives. The potential 
utility of such compounds is demonstrated by synthesis of an 
off-on fluorescent probe for the detection of phosgene. 
Results and discussion 
Palladium catalysed amination of 2-iodoBODIPYs 
We recently reported the copper catalysed amination of 2-
iodoBODIPY 1 which produces the 3-aminoBODIPY derivatives 2 
by a vicarious nucleophilic substitution (Scheme 1).12 
 
 
Scheme 1 Copper-catalysed vicarious nucleophilic amination of 2-
iodoBODIPYs.12 
 
This mode of reaction should be denied to systems in which the 
3- (and 5-) position is blocked by substitution. The ‘fully-
blocked’ BODIPY 3 was synthesised by zinc oxide catalysed 
Friedel-Crafts acylation13 of 2,4-dimethylpyrrole to give the 2-
ketopyrrole 4. BF3-mediated condensation14 with 3-ethyl-2,4-
dimethylpyrrole followed by electrophilic iodination of the 
resulting BODIPY 5 with N-iodosuccinimide15 gave the 2-
iodoBODIPY 3 (Scheme 2). 
Attempted copper catalysed amination of the 2-iodoBODIPY 3 
under our previously reported12 conditions did not produce any 
of the corresponding 2-aminoBODIPY; instead the only product 
to be identified was the protodehalogenated BODIPY 5, which 
may well result from protonation of an intermediate 
organocopper species. Inspection of the literature reveals that, 
apart from cases in which the aryl ring is strongly activated by 
electron withdrawing groups ortho- or para- to the halogen, 
there are very few reports of successful copper-catalysed 
intermolecular coupling of alkyl- or aryl-amines with aromatic 
halides carrying two ortho substituents and these generally 
require very forcing conditions.16 In contrast to this, the 
corresponding palladium-catalysed amination of highly 
hindered doubly ortho-substituted aromatic halides is more 
common.17 Table 1 shows the results of our initial screening of 
conditions for the amination of the 2-iodoBODIPY 3 with 4-
methoxyaniline. 
 
Scheme 2 Synthesis of the 1,3-dialkylated-2-iodoBODIPY 3. Reagents: 
(a) ZnO (25 mol%), rt, 5 min (55%); (b) 3-ethyl-2,4-dimethylpyrrole, 
BF3.OEt2, rt, 2 h; (c) BF3.OEt2, i-Pr2NEt, CH2Cl2, rt, 4 h (86% over two 
steps); (d) NIS, CH2Cl2, rt, 4 h (80%). (Ar = 4-MeC6H4). 
 
 
Table 1 Variation of conditions for amination of 2-iodoBODIPY 
3 
 
 
Entrya Ligand Pd source %Pdb Base Yieldc 
1 XantPhos Pd2(dba)3 10 Cs2CO3 36 
2 BINAP Pd2(dba)3 10 Cs2CO3 5 
3 XPhos  Pd2(dba)3 10 Cs2CO3 71 
4 SPhos Pd2(dba)3 10 Cs2CO3 80 
5 SPhos Pd(OAc)2 10 Cs2CO3 19 
6 SPhos (LPdOMs)2d 10 Cs2CO3 96 
7 SPhos (LPdOMs)2d 5 Cs2CO3 94 
8 SPhos (LPdOMs)2d 2.5 Cs2CO3 92 
9 SPhos (LPdOMs)2d 1.2 Cs2CO3 81 
10 SPhos (LPdOMs)2d 0.5 Cs2CO3 10 
11 SPhos (LPdOMs)2d 0.1 Cs2CO3 n.r.e 
12 SPhos (LPdOMs)2d 1.2 KF n.r.e 
13 SPhos (LPdOMs)2d 1.2 K3PO4 60 
14 SPhos (LPdOMs)2d 1.2 Cs2CO3 13f 
15 SPhos (LPdOMs)2d 1.2 Cs2CO3 4g 
16 SPhos (LPdOMs)2d 1.2 Cs2CO3 n.r.e,h 
 
a Reagents and conditions: BODIPY 3 (0.203 mmol), 4-MeOC6H4NH2 
(1.01 mmol), Pd source, ligand (1.1 mol per mol Pd), base (0.345 mmol), 
1,4-dioxane (2 mL), 95 oC, 16 h. b Total palladium loading (mol%). c 
Isolated yield (%). d Di-μ-mesylbis[2′-(amino-N)[1,1′-biphenyl]-2-yl-
C]dipalladium(II) 7.18 e No reaction. f Reaction at 60 oC. g Reaction at 30 
oC. h Reaction at 20 oC. 
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The palladium catalysed reaction of the 2-iodoBODIPY 3 with 4-
methoxyaniline was first attempted using the conditions 
reported by Hiroto and Shinokubo for substitution of a 2-
bromoBODIPY with benzophenone imine (Scheme 3 and Table 
1, entry 1).9e,f This reaction did produce the desired 2-
aminoBODIPY 6a albeit in low yield (36%). Replacement of the 
chelating diphosphine XantPhos with rac-BINAP resulted in a 
lower yield (5%, entry 2) but the use of the bulky, electron-rich 
biarylmonophosphine XPhos produced a much improved 71% 
yield (entry 3). The related ligand SPhos improved the yield 
further to 80% (entry 4). Changing the metal precursor from 
Pd2(dba)3 to palladium diacetate led to a lower yield (19%, entry 
5) but the use of the cyclometalated biphenylamine palladium 
mesylate dimer 7, developed by Buchwald,18 produced an 
excellent yield of the 2-aminoBODIPY 6a (96%, entry 6). 
Reduction of the palladium loading from 10 mol% down to 1.2 
mol% resulted in a slight drop in yield (from 96% to 81%, entries 
6 – 9) but further reduction to 0.5 mol% and 0.1 mol% was 
unsuccessful (entries 10 and 11). Changing the base from 
caesium carbonate to either tripotassium phosphate or 
potassium fluoride resulted in lower yields (entry 9 vs entries 12 
and 13) as did lowering the reaction temperature from 95 oC 
(entry 9 vs entries 14 – 16). 
The conditions which represented the best compromise 
between producing the highest yield and requiring the lowest 
loading of palladium precursor and ligand were those in Table 
1, entry 8 (2.75 mol% SPhos, 1.25 mol% mesylate dimer 7, 1.5 
eq. Cs2CO3, 1,4-dioxane, 95 oC, 16 h). These conditions were 
applied to the reaction of the 2-iodoBODIPY 3 with a range of 
amines (Scheme 3). 
 
Scheme 3 Amination of 2-iodoBODIPY 3a 
 
 
 
a BODIPY 3 (0.203 mmol), amine (1.01 mmol), 7 (1.25 mol%), SPhos (2.5 
mol%), Cs2CO3 (0.345 mmol), 1,4-dioxane (2 mL), 95 oC, 16 h. 
 
Good yields were obtained with a range of anilines bearing 
electron donating (6a,d), electron withdrawing (6b,c,e), and 
sterically hindering substituents (6d,e). A rather low yield was 
obtained with a primary alkylamine (6f) and attempts to use 
secondary alkyl amines (pyrrolidine, morpholine) were 
unsuccessful, leading principally to protodehalogenation. 
 
Spectroscopic properties of 2-aminoBODIPYs 6a-f 
The absorption data for the parent 2-unsubstituted BODIPY 5 
and the 2-aminoBODIPYs 6a-f are summarized in Table 2 (left). 
All of the 2-aminoBODIPY derivatives 6a-f are essentially non-
fluorescent. Absorption data for the 4-methoxyaniline 
derivative 6a in different solvents are shown in Table 2 (right). 
For the 2-aminoBODIPY 6a the solvent dependence of the 
absorption maximum is weak; being blue-shifted by only 185 
cm-1 when the solvent is changed from toluene to acetonitrile 
(Table 2 and Fig. S2). The absorption spectra are unlike those of 
a conventional BODIPY dye1a and, in particular, feature a 
pronounced low energy tail which becomes more significant as 
the solvent polarity increases. To clarify this situation, the 
absorption spectrum was deconstructed into a series of 
Gaussian-shaped components (Figure 2), each Gaussian 
representing the vibronic component associated with an 
electronic transition. The low energy absorption envelope is 
best described as a progression of narrow (full-width at half-
maximum (FWHM) = 750 cm-1) peaks that closely resembles 
that observed for conventional BODIPY derivatives. This 
progression is assigned to the corresponding ,* absorption 
transition. The 0,0 band is located at 18,000 cm-1 (i.e., 556 nm). 
Superimposed over the ,* transition is a series of broad 
(FWHM = 3,600 cm-1) peaks, with the 0,0 band also appearing 
at 18,000 cm-1. This latter transition has the characteristics of an 
intramolecular charge-transfer transition;19 such transitions 
have been reported for other BODIPY dyes in polar solvent.20 
 
Table 2. Absorption data for compounds 5, 6a-f in THF (left) and 
for compound 6a in different solvents (right). 
 
a λabsb  
(max) 
/nm 
ε 
/104  
M-1cm-1 
 BODIPY 
6a 
solvent 
λabs  
(max) 
/nm 
ε 
/104  
M-1cm-1 
5 512 9.3  toluene 525 4.0 
6a 523 3.0  CH2Cl2 523 4.5 
6b 524 2.5  THF 523 3.0 
6c 520 3.6  EtOH 522 3.4 
6d 523 2.9  MeCN 520 3.5 
6e 522 5.1     
6f 524 2.4     
 
a BODIPY compound number. bSpectrum recorded in THF. 
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Figure 2. Deconvolution of reduced experimental absorption spectrum 
for 6a in MeCN into Gaussian components. The major components are 
interpreted as: -- peak 1 (charge transfer band); ---- peak 2 (BODIPY S0-
S1 transition); -- peak 3 (0-1 vibrational band of S0-S1); -- peak 4 (a higher 
energy vibrational band, such as NH stretching). 
 
The absence of fluorescence from the amino-substituted 
derivatives is explained as follows: The coincidental matching of 
the 0,0 transitions masks the real situation. The peak of the 
absorption band can be approximated21 as the sum of the 
excited-state energy (ES) and the corresponding re-organization 
energy T). The latter is small for a ,* state, typically being a 
few hundred wavenumbers, but substantial for a charge-
transfer state. In the latter case, important contributions arise 
from both nuclear and solvent terms.20 It is possible to estimate 
T for the charge-transfer state from the corresponding half-
width in the appropriate solvent.22 This gives a value forT of 
0.69 eV. Taking this value together with the excitation energy of 
2.36 eV (i.e., 19,000 cm-1), we reach an estimate for the excited 
state energy of 1.67 eV (i.e., 740 nm). This value can be 
compared with the difference between oxidation and reduction 
potentials (see later) of 1.81 eV; this gives a crude estimate of 
the HOMO-LUMO gap. 
Continuing this exercise, we note that the magnitude of the 
Stokes shift23 is twice that of the reorganization energy. Thus, 
the fluorescence peak for the ,* excited state is expected at 
around 575 nm while that for the charge-transfer state is 
anticipated to peak at around 1,265 nm. Conventional 
fluorescence spectrophotometers have no sensitivity in this 
spectral range. Furthermore, the emission profile will resemble 
that of the corresponding absorption transition (i.e., broad, 
featureless and low intensity) and would be difficult to resolve 
from the baseline. To exacerbate the situation, the low energy 
of the projected charge-transfer emission will favour24 rapid 
nonradiative charge recombination to restore the ground state 
but disfavour25 the radiative process. Hence the quantum yield 
should be very low. This position is illustrated pictorially by way 
of Chart 1. 
Hybridisation of the amino N atom, via protonation or amide 
formation, will raise the energy of the charge-transfer state 
while having minimal effect on the ,* state (chart 1). 
Consequently, fluorescence is expected to appear in the 550-
600 nm region. At the same time, the absorption spectrum 
should sharpen because of loss of the broad charge-transfer 
transition and the spectrum will take on the characteristics of a 
conventional BODIPY dye.1a The absorption maximum of the 2-
amino substituted BODIPYs 6a-f is red-shifted (by 300 – 450 cm-
1) compared to that of the parent system 5 (Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chart 1. Pictorial representation of the energy-level positioning for the 
,* and charge-transfer (CT) states relative to the ground state (GS). 
Panel (a) refers to the amino-substituted BODIPY while panel (b) is 
intended to mimic the situation following hybridisation of the amino N 
atom. IC = internal conversion; CR = charge recombination. 
 
Quantum chemical calculations of 2-aminoBODIPYs 
Ground state geometries were optimised using the Gaussian 09 
software26 by DFT calculations at the B3LYP/6-31G(d) level,27 
applying the polarizable continuum model28 (IEFPCM, with 
solvent=THF). Figure 3 shows the HOMO and LUMO orbitals and 
energies for the 2-unsubstituted BODIPY 5, the 2-
aminoBODIPYs 6a and 8 (as a model for alkylamine 
substitution). 
As expected for 1,3-dimethylated systems, the amine (NHR) and 
the BODIPY core are predicted to be non-coplanar which 
reduces conjugation between the nitrogen and the BODIPY. 
Consequently the nitrogen in the alkyl amine derivative 8 is 
significantly pyramidalized (the sum of bond angles at the 
nitrogen is 336.4o). Inspection of the orbitals (Fig. 3) indicates 
that the 2-amino substituent has minimal effect on the energy 
and topology of the LUMO whereas the HOMO is substantially 
delocalised onto the substituent and raised in energy, 
particularly in the case of the aniline derivative 6a. 
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Figure 3 HOMO and LUMO molecular orbitals and energies (eV) for 5, 
6a, and the 2-NHMe model BODIPY 8 (Ar = 4-MeC6H4). 
 
Crystal structure determination of 6d 
Slow diffusion of hexane into a dichloromethane solution of the 
ortho-toluidine derivative 6d succeeded in producing a 
crystalline sample suitable for analysis by X-ray diffraction 
(Figure 4).  
Figure 4 One of the two crystallographically independent molecules in 
the asymmetric unit of the structure of the 2-aminoBODIPY 6d. 
Hydrogen atoms have been omitted for clarity. The two independent 
molecules are similar hence only one is shown. 
 
The compound crystallised with Z´ = 2 where the two 
crystallographically independent molecules differ only slightly 
in their conformation (RMSD 0.219 Å, Fig. S1 shows an overlay 
of the two molecules) and hence there are two values for each 
geometric parameter quoted. The bond lengths between the 
nitrogen atoms and the benzene rings of the aniline moiety (N3-
C12 = 1.392(2) Å; N6-C42 = 1.392(2) Å) are typical of a 
conjugated aniline, whilst the corresponding distances from 
nitrogen to the BODIPY 2-position (N3-C2 = (1.4136(19) Å; N6-
C32 = 1.406(2) Å) are slightly longer as would be expected on 
the basis of reduced π-overlap due to the non-coplanarity of the 
amine and the pyrrolic plane of the BODIPY core [torsion angles 
C12-N3-C2-C1= 105.9(2)°; C42-N6-C32-C31 = 113.9(2)°]. 
 
Electrochemical properties of the 2-aminoBODIPY 6a 
A representative cyclic voltammogram of the 2-anilino BODIPY 
6a is shown in Figure 5. 
 
Figure 5 Cyclic voltammogram of the 2-aminoBODIPY 6a in MeCN with 
1.0 M tetrabutylammonium hexafluorophosphate at 20 oC, referenced 
to Ag/Ag+. Scan rate 0.2 Vs-1. 
 
The reversible one electron reduction with E½ = -1.48 V is as 
expected for a BODIPY system. In contrast, at positive potentials 
the reversible oxidation with E½ = +0.33 V is much too low to be 
related to the BODIPY and is presumably due to oxidation of the 
aniline and confirms that the lowest energy absorption 
transition should be of strong charge transfer character. The 
subsequent irreversible oxidation (Ep = +0.56 V) is also due to 
oxidation of the aniline. A final irreversible oxidation at Ep = 
+1.26 V may be due to oxidation involving the BODIPY but 
cannot sensibly be used to calculate an electrochemical band 
gap due to the multiple preceding oxidations.  
The spectroscopic, computational and electrochemical data are 
consistent with intramolecular charge transfer from the amine 
substituent. 
 
Design of a fluorescence sensor for phosgene 
Phosgene (COCl2) is a highly toxic,29 colourless gas which has 
been used in the past as a chemical warfare agent. Due to its 
high reactivity with many organic nucleophiles, phosgene has a 
number of industrial uses such as in polymer, pesticide and dye 
production.30 Reports of fluorescence-based sensors for 
phosgene are limited to systems based on: a FRET-induced 
response resulting from triphosgene induced coupling of donor 
and acceptor coumarins (limit of detection 50 µM);31a 
cyclisation of an ortho-hydroxycinnamic acid to produce a 
fluorescent coumarin (LOD 1 nM);31b and ring opening of a 
rhodamine spirodeoxylactam (LOD 50 nM).31c There are no 
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reports of a BODIPY-based phosgene sensor. For this proof of 
principle study we utilised triphosgene [(Cl3CO)2CO] as a safer 
phosgene equivalent. Sequential nucleophilic attacks on the 
carbonyl of triphosgene lead to the liberation of two further 
equivalents of phosgene. 
We envisaged that nucleophilic attack of a 2-aminoBODIPY on 
phosgene would decrease the electron-donor ability of the 
substituent. In turn, this effect would push the corresponding 
intramolecular charge-transfer transition to higher energy 
(Chart 1). At a certain point, the energy of the charge-transfer 
state would exceed that of the π,π* transition. The absorption 
spectrum would lose the broad, featureless band and acquire 
the sharp, structured profile characteristic of the π,π* state. 
Once the energy gap exceeds the amount of thermal energy 
available to the molecule, charge transfer will no longer be an 
option and fluorescence from the π,π* state would be 
observed. This description nicely summarises the situation 
found following treatment of the aniline derivative 9 with 
triphosgene. We expect the other 2-amino derivatives to show 
similar behaviour. Since the LUMO energy remains fairly 
insensitive to the nature of the substituent, the energy of the 
charge-transfer state is set by the HOMO energy. The 
substituent will have only a minor effect on the energy gap for 
the π,π* excited-singlet state. To investigate this proposal the 
2-nitroaniline derivative 6e was hydrogenated to give the 
corresponding 2-aminoaniline 9 (Scheme 4). Reaction of this 
compound with triphosgene gave the corresponding 
benzimidazolone-substituted BODIPY 10 in excellent yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4 Synthesis of the benzimidazolone 10. Reagents: (a) H2 (1 atm), 
10% Pd/C, MeOH-CH2Cl2, rt, 2 h (95%); (b) (Cl3CO)2CO, Et3N, CH2Cl2, rt, 
10 min (98%). (Ar = 4-MeC6H4). 
 
The aminoaniline derivative 9 is non-emissive, in line with the 
other 2-aminoBODIPYs 6a-f. In contrast the benzimidazolone 10 
is strongly fluorescent (λabs = 515 nm, ε = 64,000 M-1cm-1, λem = 
539 nm, Φf = 0.97 in THF, determined vs rhodamine 6G in 
ethanol,32 λex = 490 nm). Figure 6 shows the absorption and 
emission spectra of compounds 9 and 10 together with optical 
images of a solution of the aminoBODIPY 9 before and after the 
addition of triphosgene. Figure 7 shows the fluorescence 
emission spectra of a solution of the aminoaniline 9 on 
treatment with varying concentrations of triphosgene. On the 
basis of the fluorescence titration (Fig. 7, inset) the Limit of 
Detection33 for phosgene was found to be 160 nM (recalculated 
from a concentration of triphosgene = 53 nM). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Absorption spectrum (solid lines) in terms of the molar 
absorption coefficient (ε) for 9 (—) and 10 (—) and emission spectrum 
(dashed lines) of 10 (----) in THF. Optical images inset: solution of the 
BODIPY 9 (50 µM in CH2Cl2 containing 3% Et3N) before (left) and after 
(right) addition of triphosgene (25 µM). A visible light illumination; B 
illumination with hand-held lamp at 365 nm. 
Figure 7. Fluorescence emission spectra of the aminoaniline 9 (0.01 mg 
mL-1, 21 μM) in the presence of triphosgene (0 to 3.4 µM) in MeCN 
containing 3% Et3N. Graphical inset: fluorescence emission intensity at 
534 nm vs triphosgene concentration (λex = 490 nm). 
 
The sensitivity is determined by the initial concentration of the 
BODIPY aniline and the amount of phosgene; consequently this 
system should also be useful at high concentrations of 
phosgene. Although sensors based on reversible complexation 
enable dynamic reporting of analyte concentrations, a potential 
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advantage of the irreversible nature of the present reaction 
with phosgene is that it should enable use over a very wide 
range of phosgene concentrations. In order to develop a 
practical phosgene sensor, determination of the sensitivity 
towards potential competing analytes such as aldehydes and 
acid chlorides would need to be undertaken. Incorporation of 
this system into a thin-film might also enable fabrication of a 
practical solid-state sensor.  
Conclusions 
Palladium catalysed coupling of the 2-iodoBODIPY 3 with a 
range of anilines and a primary alkylamine succeeds in 
generating the corresponding 2-aminoBODIPY derivatives. The 
non-emissive behaviour of these compounds is believed to be 
the consequence of introducing a low-energy, intramolecular 
charge-transfer state where the 2-amino group is the donor and 
the dipyrrin unit is the acceptor. The energy of this state, and 
the energy gap between π,π* and charge-transfer states, is 
controlled by the energy of the HOMO. Attenuation of this 
charge transfer pathway by conversion of the 1,2-
phenylenediamine derivative 9 into the corresponding 
benzimidazolone 10 restores the fluorescence and has been 
used to demonstrate the potential for use as a fluorescence 
sensor for phosgene. 
Experimental 
General 
All manipulations involving air-sensitive materials were carried 
out using standard Schlenk line techniques under an 
atmosphere of nitrogen in flame-dried glassware. CHCl3, CH2Cl2 
and NEt3 were distilled from CaH2; MeOH and EtOH from 
magnesium; 1,4-dioxane, Et2O and THF from 
Na/benzophenone; toluene from sodium; and MeCN from 
K2CO3, under an atmosphere of nitrogen. DMF was dried over 
activated 4 Å molecular sieves and stored under nitrogen. All 
other chemicals were purchased from commercial suppliers and 
used without further purification. NMR spectra were recorded 
on either a JEOL ECS 400 or a Bruker Avance 300 instrument. All 
NMR were referenced relative to CDCl3 (δH = 7.26, δC = 77.16). 
IR spectra were recorded on a Varian 800 FT-IR Scimitar Series 
infrared spectrometer. Mass spectra were recorded on Waters 
ACQUITY UPLC LCT premier MS in positive ion mode. UV-vis and 
fluorescence spectra were recorded at 20 oC on a Shimadzu UV-
1800 and Hitachi F2500 machines respectively. Relative 
fluorescence quantum yields (Φf) were determined using dilute 
solutions with an absorbance below 0.1 at the excitation 
wavelength and using Rhodamine 6G (Φf = 0.95)32 in ethanol as 
standard. TLC was carried out on glass plates pre-coated with 
silica gel 60F254 and flash column chromatography was 
performed on Fluorochem LC3025 (40-63 μm) silica gel. 
Compound 4,34,13 was prepared by a modification to the 
reported procedure (see Electronic Supplementary 
Information). 
 
X-ray crystal structure analysis 
Single crystals were prepared by slow diffusion of hexane into a 
solution of the compound in chloroform. Crystal structure data 
were collected at 150 K on an Rigaku Oxford Diffraction  Gemini 
A Ultra using CuKα radiation (λ = 1.54184 Å) and equipped with 
an Oxford Cryosystems Cryostream open-flow N2 cooling 
device. Cell refinement, data collection, reduction and 
absorption correction were carried out using Rigaku Oxford 
Diffraction CrysalisPro.35 The intensities were corrected for 
absorption semi-empirically based on repeated, symmetry-
equivalent reflections. 
The structure was solved via direct methods and refined on F2 
values for all unique data. Refinements were performed using 
SHELXL36 within the Olex2 program.37 All non-hydrogen atoms 
were modelled as anisotropic. Hydrogen atoms were positioned 
geometrically and defined as riding on their parent atoms 
except for those bound to heteroatoms, which were located 
using peaks in the Fourier difference map. 
 
Materials 
2-Ethyl-4,4-difluoro-1,3,5,7-tetramethyl-8-(4-methylphenyl)-
4-bora-3a,4a-diaza-s-indacene 5. (3,5-Dimethyl-1H-pyrrol-2-
yl)(p-tolyl)methanone 4 (2.11 g, 9.88 mmol) was taken in dry 
CH2Cl2 (60 mL). 3-Ethyl-2,4-dimethyl-1H-pyrrole (1.73 mL, 12.8 
mmol) and BF3.OEt2 (1.20 mL, 12.0 mmol) were added and the 
resulting solution was stirred at room temperature for 2 h. The 
mixture was then neutralized with N,N-diisopropylethylamine 
(7.66 g, 59.3 mmol) and treated with BF3.OEt2 (9.10 g, 79.1 
mmol) and then the mixture was stirred at room temperature 
for 4 h. The crude mixture was washed with water (200 mL). The 
aqueous layer was back extracted with CH2Cl2 (2 × 100 mL). The 
combined organic layers were dried (MgSO4) and the solvent 
was removed under reduced pressure. The resulting orange 
crude product was purified by column chromatography 
(CH2Cl2:petroleum ether 1:3) to give the title compound 5 as an 
orange solid (3.13 g, 86%), mp 141-142 °C. Rf = 0.3 
(CH2Cl2:petroleum ether 1:3). 1H NMR (300 MHz, CDCl3) δ 7.19 
(d, J = 7.9 Hz, 2H), 7.05 (d, J = 7.9 Hz, 2H), 5.85 (s, 1H), 2.46 (s, 
3H), 2.45 (s, 3H), 2.35 (s, 3H), 2.22 (q, J = 7.5 Hz, 2H), 1.29 (s, 
3H), 1.24 (s, 3H), 0.90 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) 
δ 155.16, 153.64, 141.98, 141.33, 139.41, 138.70, 133.34, 
132.33, 131.43, 131.14, 129.75, 127.91, 120.46, 21.45, 17.09, 
14.59, 14.48, 14.41, 12.62, 11.82. 11B NMR (96 MHz, CDCl3) δ 
0.77 (t, JB-F = 33.1 Hz). 19F NMR (282 MHz, CDCl3) δ -146.02 (q, JF-
B =33.1 Hz). IR (neat): υmax/cm-1: 2966, 1713, 1539, 1516, 1310, 
1191, 1053, 974, 754. HRMS-ES Calcd for C22H25N211BF2 + H+: 
367.2157, found: 367.2162. 
6-Ethyl-4,4-difluoro-2-iodo-1,3,5,7-tetramethyl-8-(4-
methylphenyl)-4-bora-3a,4a-diaza-s-indacene 3. 2-Ethyl-4,4-
difluoro-1,3,5,7-tetramethyl-8-(4-methylphenyl)-4-bora-3a,4a-
diaza-s-indacene 5 (2.16 g, 5.92 mmol) was taken in dry CH2Cl2 
(35 mL). N-Iodosuccinimide (1.39 g, 5.92 mmol) in CH2Cl2 (40 
mL) was added to the mixture dropwise. The mixture was 
stirred at room temperature for 4 h. The crude product mixture 
was washed with H2O (3 x 100 mL). The aqueous layer was back 
extracted with CH2Cl2 (2 × 30 mL). The combined organic layers 
were dried (MgSO4) and the solvent was removed under 
reduced pressure. The resulting orange crude product was 
purified by column chromatography (CH2Cl2:petroleum ether 
1:1) to give the title compound 3 as an orange solid (2.35 g, 
80%), mp 220-221 ᵒC. Rf = 0.5 (CH2Cl2:petroleum ether 1:1). 1H 
NMR (300 MHz, CDCl3) δ 7.22 (d, J = 7.9 Hz, 2H), 7.05 (d, J = 7.9 
Hz, 2H), 2.54 (s, 3H), 2.48 (s, 3H), 2.37 (s, 3H), 2.24 (q, J = 7.5 Hz, 
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2H), 1.30 (s, 3H), 1.25 (s, 3H), 0.92 (t, J = 7.5 Hz, 3H). 13C NMR 
(75 MHz, CDCl3) δ 157.80, 152.75, 141.92, 141.03, 140.98, 
139.06, 134.52, 132.14, 131.92, 130.68, 129.91, 127.85, 83.38, 
21.49, 17.13, 16.64, 15.69, 14.43, 12.87, 12.04. 11B NMR (96 
MHz, CDCl3) δ 0.68 (t, JB-F = 32.8 Hz). 19F NMR (282 MHz, CDCl3) 
δ -145.74 (q, JF-B =32.8 Hz). IR (neat): υmax/cm-1: 2966, 2931, 
1532, 1401, 1310, 1179, 1070, 976, 754. HRMS-ES Calcd for 
C22H24N211BF2127I + H+: 493.1124, found: 493.1131. 
General procedure for palladium catalysed amination. 
2-Ethyl-4,4-difluoro-2-iodo-1,3,5,7-tetramethyl-8-(4-
methylphenyl)-4-bora-3a,4a-diaza-s-indacene 3 (0.10 g, 0.20 
mmol), the amine (1.01 mmol), di((2-(2'-amino-1,1'-
biphenyl))palladium(II) methanesulfonate dimer 7 (1.87 mg, 
2.50 μmol, 1.25 mol%) SPhos (2.30 mg, 5.50 μmol, 2.75 mol %), 
and Cs2CO3 (0.11 g, 0.35 mmol) were taken in a flame-dried 
Schlenk tube and flushed with N2 several times. Dry 1,4-dioxane 
(2 mL) was then added and the mixture was stirred at 95 °C for 
16 h. The mixture was diluted with ethyl acetate (30 mL) and 
washed with water (2 × 100 mL). The organic layer was dried 
(MgSO4) and the solvent was removed under reduced pressure. 
The crude product was purified by column chromatography 
(ethyl acetate:petroleum ether mixtures). 
6-Ethyl-4,4-difluoro-2-((4-methoxyphenyl)amino)-8-(4-
methylphenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-
indacene 6a. According to the general procedure for palladium 
catalysed amination, 2-ethyl-4,4-difluoro-2-iodo-1,3,5,7-
tetramethyl-8-(4-methylphenyl)-4-bora-3a,4a-diaza-s-indacene 
3 (0.10 g, 0.20 mmol) was reacted with p-anisidine (0.12 g, 1.01 
mmol). The crude product was purified by column 
chromatography (ethyl acetate:petroleum ether 1:7) to give the 
title compound 6a as a dark purple solid (0.09 g, 92%), mp 240-
241 ̊C. Rf = 0.25 (ethyl acetate:petroleum ether 1:7). 1H NMR 
(300 MHz, CDCl3) δ 7.20 (d, J = 7.9 Hz, 2H), 7.08 (d, J = 7.9 Hz, 
2H), 6.65 (d, J = 8.9 Hz, 2H), 6.40 (d, J = 8.9 Hz, 2H), 3.65 (s, 3H), 
2.48 (s, 3H), 2.35 (s, 3H), 2.34 (s, 3H), 2.24 (q, J = 7.5 Hz, 2H), 
1.26 (s, 3H), 1.15 (s, 3H), 0.92 (t, J = 7.5 Hz, 3H). 13C NMR (101 
MHz, CDCl3) δ 155.50, 152.52, 151.71, 141.13, 140.86, 139.59, 
138.84, 136.73, 133.31, 132.44, 131.75, 131.56, 129.84, 129.30, 
128.03, 114.89, 114.31, 55.83, 21.53, 17.15, 14.67, 12.72, 11.95, 
11.19. 11B NMR (96 MHz, CDCl3) δ 0.78 (t, JB-F = 32.2 Hz); 19F NMR 
(282 MHz, CDCl3) δ -145.93 (q, JF-B =32.2 Hz). IR (neat): υmax/cm-
1: 3399, 2962, 2927, 2360, 1541, 1508, 1477, 1184, 1005, 798. 
HRMS-ES Calcd for C29H32N311BF2O + H+: 488.2686, found: 
488.2685. 
2-((4-Chlorophenyl)amino)-6-ethyl-4,4-difluoro-1,3,5,7-
tetramethyl-8-(4-methylphenyl)-4-bora-3a,4a-diaza-s-
indacene 6b. According to the general procedure for palladium 
catalysed amination, 2-ethyl-4,4-difluoro-2-iodo-1,3,5,7-
tetramethyl-8-(4-methylphenyl)-4-bora-3a,4a-diaza-s-indacene 
3 (0.10 g, 0.20 mmol) was reacted with 4-chloroaniline (0.13 g, 
1.01 mmol). The crude product was purified by column 
chromatography (ethyl acetate:petroleum ether 1:7) to give the 
title compound 6b as a dark purple solid (0.09 g, 85%), mp 270-
271 ̊C. Rf = 0.37 (ethyl acetate:petroleum ether 1:7).1H NMR 
(300 MHz, CDCl3) δ 7.21 (d, J = 7.9 Hz, 2H), 7.07 (d, J = 7.9 Hz, 
2H), 7.00 (d, J = 8.6 Hz, 2H), 6.37 (d, J = 8.6 Hz, 2H), 4.77 (s, 1H), 
2.49 (s, 3H), 2.35 (s, 3H), 2.32 (s, 3H), 2.25 (q, J = 7.6 Hz, 2H), 
1.27 (s, 3H), 1.13 (s, 3H), 0.92 (t, J = 7.6 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 156.51, 150.89, 145.55, 141.34, 140.12, 138.88, 
137.01, 133.70, 132.20, 131.82, 130.03, 129.82, 129.10, 127.87, 
124.83, 122.55, 114.17, 21.47, 17.08, 14.55, 12.74, 12.76, 11.94, 
11.09. 11B NMR (96 MHz, CDCl3) δ 0.69 (t, JB-F = 33.0 Hz). 19F NMR 
(282 MHz, CDCl3) δ -146.05 (q, JF-B = 33.0 Hz). IR (neat): υmax/cm-
1: 3357, 2962, 2923, 2360, 1661, 1597, 1539, 1490, 1259, 1074, 
1009, 796. HRMS-ES Calcd for C28H29N311B19F235Cl + Na+: 
514.2009, found: 514.2012. 
2-((4-Cyanophenyl)amino)-6-ethyl-4,4-difluoro-1,3,5,7-
tetramethyl-8-(4-methylphenyl)-4-bora-3a,4a-diaza-s-
indacene 6c. According to the general procedure for palladium 
catalysed amination, 2-ethyl-4,4-difluoro-2-iodo-1,3,5,7-
tetramethyl-8-(4-methylphenyl)-4-bora-3a,4a-diaza-s-indacene 
3 (0.10 g, 0.20 mmol) was reacted with 4-cyanoaniline (0.12 g, 
1.01 mmol). The crude product was purified by column 
chromatography (ethyl acetate:petroleum ether 1:7) to give the 
title compound 6c as a dark red solid (0.05 g, 51%), mp 282-
286 ̊C. Rf = 0.25 (ethyl acetate:petroleum ether 1:7).1H NMR 
(300 MHz, CDCl3) δ 7.32 (d, J = 8.6 Hz, 2H), 7.22 (d, J = 7.9 Hz, 
2H), 7.07 (d, J = 7.9 Hz, 2H), 6.45 (d, J = 8.6 Hz, 2H), 5.25 (s, 1H), 
2.50 (s, 3H), 2.36 (s, 3H), 2.31 (s, 3H), 2.29 – 2.18 (m, 2H), 1.28 
(s, 3H), 1.12 (s, 3H), 0.93 (t, J = 7.5 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 157.91, 150.61, 149.58, 141.59, 140.82, 139.05, 
136.71, 134.29, 133.79, 132.25, 132.00, 129.89, 128.79, 127.94, 
127.80, 120.16, 112.90, 99.97, 21.45, 17.08, 14.45, 12.84, 11.99, 
11.64, 11.03. 11B NMR (96 MHz, CDCl3) δ 0.67 (t, JB-F = 32.5 
Hz).19F NMR (282 MHz, CDCl3) δ -145.91 (q, JF-B = 32.5 Hz). IR 
(neat): υmax/cm-1: 3386, 2964, 2928, 2212, 1668, 1606, 1537, 
1515, 1314, 1261, 1200, 1074, 1005, 800. HRMS-ES Calcd for 
C29H29N411B19F2 + Na+: 505.2351, found: 505.2355. 
6-Ethyl-4,4-difluoro-1,3,5,7-tetramethyl-8-(4-methylphenyl)-
2-((2-methylphenyl)-amino)-4-bora-3a,4a-diaza-s-indacene 
6d. According to the general procedure for palladium catalysed 
amination, 2-ethyl-4,4-difluoro-2-iodo-1,3,5,7-tetramethyl-8-
(4-methylphenyl)-4-bora-3a,4a-diaza-s-indacene 3 (0.10 g, 0.20 
mmol) was reacted with o-toluidine (0.11 g, 1.01 mmol). The 
crude product was purified by column chromatography (ethyl 
acetate:petroleum ether 1:7) to give the title compound 6d as a 
dark purple solid (0.09 g, 90%), mp 201-202 ̊C. Rf = 0.37 (ethyl 
acetate:petroleum ether 1:7). 1H NMR (300 MHz, CDCl3) δ 7.20 
(d, J = 7.9 Hz, 2H), 7.09 (d, J = 7.9 Hz, 2H), 6.98 (d, J = 7.3 Hz, 1H), 
6.96 – 6.89 (m, 1H), 6.59 (td, J = 7.4, 1.1 Hz, 1H), 6.24 (dd, J = 
8.0, 0.9 Hz, 1H), 4.54 (s, 1H), 2.49 (s, 3H), 2.35 (s, 3H), 2.33 (s, 
3H), 2.25 (q, J = 7.6 Hz, 2H), 2.17 (s, 3H), 1.27 (s, 3H), 1.14 (s, 
3H), 0.92 (t, J = 7.6 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 155.70, 
151.54, 144.76, 141.18, 139.69, 138.79, 137.01, 133.36, 132.34, 
131.56, 130.94, 130.25, 129.78, 129.23, 127.94, 127.07, 121.52, 
117.85, 111.59, 21.47, 17.52, 17.09, 14.60, 12.68, 11.90, 11.82, 
11.11. 11B NMR (96 MHz, CDCl3) δ 0.74 (t, JB-F = 32.5 Hz). 19F NMR 
(282 MHz, CDCl3) δ -146.13 (q, JF-B = 32.5 Hz). IR (neat): υmax/cm-
1: 3410, 2962, 2972, 2868, 1535, 1475, 1323, 1303, 1179, 1054, 
977, 750. HRMS-ES Calcd for C29H32N311B19F2 + Na+: 494.2555, 
found: 494.2561. 
6-Ethyl-4,4-difluoro-1,3,5,7-tetramethyl-8-(4-methylphenyl)-
2-(2-nitrophenyl)amino)-4-bora-3a,4a-diaza-s-indacene 6e. 
According to the general procedure for palladium catalysed 
amination, 2-ethyl-4,4-difluoro-2-iodo-1,3,5,7-tetramethyl-8-
(4-methylphenyl)-4-bora-3a,4a-diaza-s-indacene 3 (0.10 g, 0.20 
mmol) was reacted with 2-nitroaniline (0.14 g, 1.01 mmol).The 
crude product was purified by column chromatography (ethyl 
acetate:petroleum ether 1:9) to give the title compound 6e as a 
dark red solid (0.08 g, 67%), mp 220-222 ̊C. Rf = 0.25 (ethyl 
acetate:petroleum ether 1:9). 1H NMR (300 MHz, CDCl3) δ 8.72 
(s, 1H), 8.10 (dd, J = 8.6, 1.5 Hz, 1H), 7.31 – 7.25 (m, 1H), 7.22 (d, 
J = 8.0 Hz, 2H), 7.09 (d, J = 8.0 Hz, 2H), 6.63 (ddd, J = 8.4, 7.0, 1.2 
Hz, 1H), 6.55 (dd, J = 8.6, 1.1 Hz, 1H), 2.51 (s, 3H), 2.36 (s, 3H), 
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2.34 (s, 3H), 2.26 (q, J = 7.6 Hz, 2H), 1.29 (s, 3H), 1.14 (s, 3H), 
0.94 (t, J = 7.6 Hz, 3H). 13C NMR (176 MHz, CDCl3) δ 158.17, 
149.08, 144.97, 141.65, 140.93, 139.07, 136.36, 136.10, 134.39, 
132.32, 132.34, 131.97, 129.91, 128.90, 127.80, 127.13, 126.55, 
116.75, 115.74, 21.46, 17.09, 14.46, 12.88, 12.02, 11.68, 11.02. 
11B NMR (96 MHz, CDCl3) δ 0.71 (t, JB-F = 32.6 Hz). 19F NMR (282 
MHz, CDCl3) δ -146.06 (q, JF-B = 32.6 Hz). IR (neat): υmax/cm-1: 
3439, 3362, 2920, 1910, 1642, 1595, 1527, 1503, 1313, 1257, 
1089, 938, 734. HRMS-ES Calcd for C28H29N411B19F2O2 + Na+: 
525.2249, found: 525.2256. 
6-Ethyl-4,4-difluoro-2-(hexylamino)-1,3,5,7-tetramethyl-8-(4-
methylphenyl)-4-bora-3a,4a-diaza-s-indacene 6f. According to 
the general procedure for palladium catalysed amination, 2-
ethyl-4,4-difluoro-2-iodo-1,3,5,7-tetramethyl-8-(4-
methylphenyl)-4-bora-3a,4a-diaza-s-indacene 3 (0.10 g, 0.20 
mmol) was reacted with hexylamine (0.10 g, 1.01 mmol). The 
crude product was purified by column chromatography (ethyl 
acetate:petroleum ether 1:7) to give the title compound 6f as a 
dark purple solid (0.03 g, 31%), mp 200-201 ̊C. Rf = 0.49 (ethyl 
acetate:petroleum ether 1:7). 1H NMR (300 MHz, CDCl3) δ 7.19 
(d, J = 8.0 Hz, 2H), 7.06 (d, J = 8.0 Hz, 2H), 2.81 (t, J = 7.4 Hz, 2H), 
2.50 (s, 3H), 2.46 (s, 3H), 2.37 (s, 3H), 2.26-2.18 (m, 2H), 1.24-
1.20 (m, 8H), 1.19-1.15 (m, 6H), 0.91 (t, J = 7.6 Hz, 3H), 0.82 – 
0.76 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 152.81, 149.75, 
140.03, 139.56, 138.53, 137.95, 132.70, 132.12, 130.76, 129.78, 
129.61, 128.56, 128.17, 50.02, 31.69, 30.80, 26.71, 22.62, 21.44, 
17.06, 14.67, 14.04, 12.41, 12.09, 11.72, 10.85. 11B NMR (96 
MHz, CDCl3) δ 0.70 (t, JB-F = 32.5 Hz). 19F NMR (282 MHz, CDCl3) 
δ -146.13 (q, JF-B = 32.5 Hz). IR (neat): υmax/cm-1: 3290, 2962, 
2359, 1544, 1411, 1260, 1017, 797. HRMS-ES Calcd for 
C28H38N311B19F2 + H+: 466.3205, found: 466.3205. 
6-Ethyl-4,4-difluoro-1,3,5,7-tetramethyl-8-(4-methylphenyl)-
2-(2-aminophenyl)amino)-4-bora-3a,4a-diaza-s-indacene 9. 6-
Ethyl-4,4-difluoro-1,3,5,7-tetramethyl-8-(4-methylphenyl)-2-
((2-nitrophenyl)amino)-4-bora-3a,4a-diaza-s-indacene 6e (0.05 
g, 0.10 mmol) was dissolved in CH2Cl2 (1 mL) and MeOH ( 3 mL). 
10% Pd/C (0.05 g) was added. The mixture was stirred under 
nitrogen for 15 min and the nitrogen line was replaced with a 
hydrogen-filled balloon. The mixture was stirred at room 
temperature for 2 h and then filtered through Celite, washing 
with CH2Cl2. The solvent was removed under reduced pressure. 
The crude product was purified by column chromatography 
(CH2Cl2) to give the title compound 9 as a dark purple solid (0.05 
g, 95%), mp 215-218  ̊C. Rf = 0.25 (CH2Cl2). 1H NMR (300 MHz, 
CDCl3) δ 8.72 (s, 1H), 8.10 (dd, J = 8.6, 1.5 Hz, 1H), 7.31 – 7.25 
(m, 1H), 7.22 (d, J = 8.0 Hz, 2H), 7.09 (d, J = 8.0 Hz, 2H), 6.63 
(ddd, J = 8.4, 7.0, 1.2 Hz, 1H), 6.55 (dd, J = 8.6, 1.1 Hz, 1H), 2.51 
(s, 3H), 2.36 (s, 3H), 2.34 (s, 3H), 2.26 (q, J = 7.6 Hz, 2H), 1.29 (s, 
3H), 1.14 (s, 3H), 0.94 (t, J = 7.6 Hz, 3H). 13C NMR (176 MHz, 
CDCl3) δ 157.90, 150.61, 149.57, 141.58, 140.82, 139.05, 
136.72, 134.29, 133.79, 132.24, 131.99, 129.90, 128.78, 127.92, 
127.79, 120.19, 112.90, 99.92, 21.46, 17.08, 14.47, 12.85, 12.00, 
11.65, 11.04. 11B NMR (96 MHz, CDCl3) δ 0.77 (t, JB-F = 32.4 Hz). 
19F NMR (282 MHz, CDCl3) δ -146.00 (q, JF-B = 32.4 Hz). IR (neat): 
υmax/cm-1: 3440, 3362, 2921, 2360, 1642, 1595, 1527, 1503, 
1413, 1312, 1257, 1090, 733. HRMS-ES Calcd for C28H31N411B19F2 
+ H+: 473.2688, found: 473.2690. 
2-(2-Benzimidazolinon-l-yl)-6-ethyl-4,4-difluoro-1,3,5,7-
tetramethyl-8-(4-methylphenyl)-4-bora-3a,4a-diaza-s-
indacene 10. 6-Ethyl-4,4-difluoro-1,3,5,7-tetramethyl-8-(4-
methylphenyl)-2-((2-aminophenyl)amino)-4-bora-3a,4a-diaza-
s-indacene 9 (0.02 g, 0.09 mmol) was dissolved in dry CH2Cl2 (10 
mL). A solution of triethylamine (0.09 g, 0.71 mmol) and 
triphosgene (8.70 mg, 0.29 mmol) in CH2Cl2 (1 mL) was added. 
The mixture was stirred at room temperature for 10 min. The 
solvent was removed under reduced pressure and the crude 
product was purified by column chromatography (CH2Cl2:ethyl 
acetate 10:1) to give the title compound 10 as an orange solid 
(0.04 g, 98%), mp 205-206  ̊C. Rf = 0.25 (CH2Cl2:ethyl acetate 
10:1). 1H NMR (300 MHz, CDCl3) δ 10.37 (s, 1H), 7.21 (d, J = 8.6 
Hz, 2H), 7.12 (d, J = 8.6 Hz, 2H), 7.07 – 7.04 (m, 1H), 7.02-6.90 
(m, 2H), 6.64 (d, J = 7.0 Hz, 1H), 2.53 (s, 3H), 2.34 (s, 6H), 2.27 
(q, J = 7.5 Hz, 2H), 1.30 (s, 3H), 1.13 (s, 3H), 0.95 (t, J = 7.5 Hz, 
3H). 13C NMR (75 MHz, CDCl3) δ 158.98, 155.23, 148.65, 142.04, 
141.26, 139.05, 136.73, 134.71, 132.67, 131.89, 131.01, 129.92, 
129.80, 128.90, 128.17, 128.00, 127.73, 122.69, 122.12, 121.55, 
109.99, 108.91, 21.44, 17.11, 14.40, 12.97, 12.07, 11.87, 11.24. 
11B NMR (96 MHz, CDCl3) δ 0.78 (t, JB-F = 32.0 Hz). 19F NMR (282 
MHz, CDCl3) δ -145.24 (dq, JF-F = 107.0, JF-B = 32.0 Hz), -146.10 
(dq, JF-F = 107.0, JF-B = 32.0 Hz). IR (neat): υmax/cm-1: 3440, 3362, 
3233, 2917, 2274, 2119, 1707, 1641, 1594, 1569, 1531, 1503, 
1387, 1257, 1089, 820, 734. HRMS-ES Calcd for C29H29N410B19F2 
+ Na+: 520.2336, found: 520.2337. 
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